申请人:Janssen Pharmaceutica N.V.
公开号:US04665075A1
公开(公告)日:1987-05-12
Novel derivatives of hydroxy- or amino-substituted (piperidinylalkyl)quinazolines which are useful agents in the treatment of warmblooded animals suffering from diseases according to the vascular bed in which excessive serotonin release occurs.
新颖的羟基或氨基取代的(哌啶基烷基)喹唑啉衍生物,可用作治疗患有根据发生过多血清素释放的血管床疾病的温血动物的药物。